Singapore markets closed

CASI Pharmaceuticals, Inc. (CASI)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.3000+0.0100 (+0.30%)
At close: 04:00PM EDT
3.5000 +0.20 (+6.06%)
After hours: 05:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 43.49M
Enterprise value 33.96M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.28
Price/book (mrq)1.80
Enterprise value/revenue 1.00
Enterprise value/EBITDA 0.22

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 346.40%
S&P500 52-week change 326.36%
52-week high 38.4800
52-week low 31.8500
50-day moving average 33.0164
200-day moving average 34.0988

Share statistics

Avg vol (3-month) 3201.02k
Avg vol (10-day) 318.61k
Shares outstanding 513.4M
Implied shares outstanding 613.4M
Float 85.44M
% held by insiders 147.45%
% held by institutions 18.44%
Shares short (30 Apr 2024) 446.33k
Short ratio (30 Apr 2024) 41.25
Short % of float (30 Apr 2024) 40.52%
Short % of shares outstanding (30 Apr 2024) 40.35%
Shares short (prior month 28 Mar 2024) 482.18k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 302 Jun 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -79.51%
Operating margin (ttm)-50.32%

Management effectiveness

Return on assets (ttm)-18.42%
Return on equity (ttm)-57.65%

Income statement

Revenue (ttm)33.88M
Revenue per share (ttm)2.54
Quarterly revenue growth (yoy)-55.00%
Gross profit (ttm)N/A
EBITDA -21.54M
Net income avi to common (ttm)-26.96M
Diluted EPS (ttm)-2.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)30.77M
Total cash per share (mrq)2.37
Total debt (mrq)21.24M
Total debt/equity (mrq)87.89%
Current ratio (mrq)3.55
Book value per share (mrq)1.81

Cash flow statement

Operating cash flow (ttm)-19.97M
Levered free cash flow (ttm)-13.71M